- Home
- CHMG vs FDMT Comparison
CHMG vs FDMT Comparison
Compare CHMG & FDMT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CHMG
- FDMT
- Stock Information
- Founded
- CHMG 1833
- FDMT 2013
- Country
- CHMG United States
- FDMT United States
- Employees
- CHMG N/A
- FDMT N/A
- Industry
- CHMG Major Banks
- FDMT Biotechnology: Pharmaceutical Preparations
- Sector
- CHMG Finance
- FDMT Health Care
- Exchange
- CHMG Nasdaq
- FDMT Nasdaq
- Market Cap
- CHMG 224.0M
- FDMT 192.2M
- IPO Year
- CHMG N/A
- FDMT 2020
- Fundamental
- Price
- CHMG $49.83
- FDMT $4.15
- Analyst Decision
- CHMG Hold
- FDMT Buy
- Analyst Count
- CHMG 3
- FDMT 10
- Target Price
- CHMG $55.00
- FDMT $32.33
- AVG Volume (30 Days)
- CHMG 13.7K
- FDMT 483.9K
- Earning Date
- CHMG 07-17-2025
- FDMT 08-07-2025
- Dividend Yield
- CHMG 2.64%
- FDMT N/A
- EPS Growth
- CHMG N/A
- FDMT N/A
- EPS
- CHMG 4.74
- FDMT N/A
- Revenue
- CHMG $96,163,000.00
- FDMT $23,000.00
- Revenue This Year
- CHMG $11.98
- FDMT $13,048.65
- Revenue Next Year
- CHMG $8.47
- FDMT N/A
- P/E Ratio
- CHMG $10.22
- FDMT N/A
- Revenue Growth
- CHMG 0.44
- FDMT N/A
- 52 Week Low
- CHMG $40.71
- FDMT $2.24
- 52 Week High
- CHMG $55.73
- FDMT $28.93
- Technical
- Relative Strength Index (RSI)
- CHMG 57.07
- FDMT 54.29
- Support Level
- CHMG $43.20
- FDMT $3.73
- Resistance Level
- CHMG $50.00
- FDMT $4.13
- Average True Range (ATR)
- CHMG 1.69
- FDMT 0.29
- MACD
- CHMG 0.12
- FDMT -0.06
- Stochastic Oscillator
- CHMG 77.50
- FDMT 50.00
About CHMG Chemung Financial Corp
Chemung Financial Corp is a bank holding firm. Through its subsidiaries, the company provides various financial services, including demand, savings, and time deposits, commercial, residential, and consumer loans, letters of credit, wealth management services, employee benefit plans, insurance products, mutual funds, and brokerage services, among others. The company's reportable segments are Core Banking, Wealth Management (WMG) services, and Holding company and CFS. Maximum revenue is generated from the Core Banking segment, which derives revenue by attracting deposits from the general public and using such funds to originate different types of loans, and to invest in securities. The Wealth Management (WMG) services segment provides trust and investment advisory services to clients.
About FDMT 4D Molecular Therapeutics Inc.
4D Molecular Therapeutics Inc is a clinical-stage gene therapy company engaged in the development of product candidates using targeted and evolved AAV vectors. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-125, 4D-110, and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector) 4D-310.